AI radiology software to improve patient care

The latest upgrade of Quantib® Prostate obtains FDA clearance

Quantib® Prostate 2.0, our AI Powered Solution for Prostate MRI Reading and Reporting has received FDA clearance. Therefore, added to its CE mark, this upgrade is available in both Europe and the US.  

Read the full statement
200511 - QP PSA density bannaer




Quantib® Prostate

Quantib Prostate video - Short


The FDA cleared and CE marked zero-footprint artificial intelligence-based software provides a workflow for the detection of abnormalities on MRI prostate scans.  

Learn more 

Quantib® Neurodegenerative



The FDA cleared and CE marked solution offers automated segmentation of brain structures and white matter hyperintensities.

Learn more 


At Quantib, we are focused on improving patient care by bringing artificial intelligence (AI) into clinical practice.

Started in 2012 as a spin-out from Erasmus MC, University Medical Center Rotterdam, Quantib now has AI partnerships with the three largest academic hospitals in the Netherlands and with hospitals and private providers internationally.

Meet the team

Learn from our resources


The Ultimate Guide to AI in Prostate Cancer

AI in prostate cancer - homepage image-1

How does artificial intelligence work? What are promising AI applications in the prostate cancer pathway? Which solutions are available now?

Learn more 

How can AI Support a Radiologist?


There is a wide range of opportunities to improve the image-based diagnostic workflow even before the images are ready for reporting and reconstruction takes place. Specifically in the context of prostate MRI, what are the various value-adds that AI can offer? 

Learn more         Find other articles

What customers say about us


The tremendous value Quantib® ND adds is that the software delivers quantified information for our dementia patients and objective tracking of disease progression for our MS patients. Additionally, the software is remarkably user-friendly, enabling me to rapidly deliver even better funded, more detailed radiology reports to my clinicians.

Anna Sofie Knoepfli | Neuroradiologist at Swiss Medical, Clinique Du Genolier, Switzerland

Using Quantib® ND enables us to provide our clinicians with valuable objective information derived from our MRI scans. Comparing the patient's results to a non-biased reference population makes it easier for clinicians to give patients insights into their atrophy development.

Mario Muto | Director Diagnostic and Interventional Neuroradiology unit at Cardarelli Hospital, Naples

Quantib® ND clearly enables constructive multidisciplinary meetings by enabling efficient decision making. It provides a comprehensive overview of imaging results and compares outcomes to a normative database, therefore it enhances the quality of care we can deliver to our patients.

John van Swieten | Professor Genetics of Dementia at Erasmus MC, Rotterdam

Curious for more detailed info on Quantib® Prostate or Quantib® ND?

We are happy to schedule a call and give you the full tour of the solutions during a video call.